Rubicon Research IPO subscribed at 48 times on final day
Rubicon Research, a pharmaceutical company, has seen its initial public offering (IPO) subscribed 48 times on the third day of bidding today.
Rubicon Research, a pharmaceutical company, has seen its initial public offering (IPO) subscribed 48 times on the third day of bidding today.